Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $974,787 - $1.73 Million
-44,128 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $4.31 Million - $6.5 Million
-216,548 Reduced 83.07%
44,128 $1.04 Million
Q3 2018

Nov 14, 2018

SELL
$12.1 - $28.85 $2.5 Million - $5.97 Million
-207,000 Reduced 44.26%
260,676 $7.52 Million
Q2 2018

Aug 14, 2018

SELL
$7.93 - $15.79 $4.54 Million - $9.05 Million
-573,000 Reduced 55.06%
467,676 $5.72 Million
Q4 2017

Feb 14, 2018

BUY
$3.98 - $7.37 $4.14 Million - $7.67 Million
1,040,676
1,040,676 $7.64 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.26B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.